Recent Finacing
Recent Raise
Fate Therapeutics develops small-molecule and biologic stem cell modulators using iPSC and adult stem cell biology to enhance HSC proliferation, homing, and therapies, including FT1050 in cord-blood transplant trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Fate Therapeutics.
